Entering text into the input field will update the search result below

CRISPR Therapeutics AG's (CRSP) CEO Sam Kulkarni At Piper Sandler 33rd Annual Virtual Healthcare Conference (Transcript)

Dec. 02, 2021 2:43 PM ETCRISPR Therapeutics AG (CRSP)
SA Transcripts profile picture
SA Transcripts

CRISPR Therapeutics AG (NASDAQ:CRSP) Piper Sandler 33rd Annual Virtual Healthcare Conference Call December 2, 2021 1:00 PM ET

Company Participants

Sam Kulkarni - Chief Executive Officer

Conference Call Participants

Ted Tenthoff - Piper Sandler

Disclaimer*: This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to help you navigate the audio should the corresponding text be unclear. The machine-assisted output provided is partly edited and is designed as a guide.

Ted Tenthoff

00:05 Hi, everybody. My name is Ted Tenthoff. I’m a Senior Biotechnology Analyst at Piper Sandler. And thanks for joining us for this year's virtual healthcare care conference. CRISPR is the leading developer of CRISPR Cas9, [indiscernible] gene editing therapies. The company has demonstrated the curative potential of CTX001 in sickle cell disease and beta thalassemia.

00:27 Additionally, CRISPR is advancing a pipeline of three gene edited CAR-T programs and also a potentially curative therapy for type 1 diabetes with partner ViaCyte. With us from CRISPR is my good friend and CEO, Sam Kulkarni. Sam thanks so much being with us today.

Sam Kulkarni

00:44 Thank you for having us.

Ted Tenthoff

00:46 So, at this point, I believe everyone knows [Technical Difficulty] maybe you can provide us kind of a high level view of your approach to developing this revolutionary technology, starting by gene editing therapies and ultimately moving in vivo.

Sam Kulkarni

01:04 Yeah. Thank you, Ted. It's nearly ten years since Dr. Emmanuelle Charpentier and Dr. Jennifer Doudna developed the CRISPR technology. It's hard to believe that this elegant system for engineering DNA came out of bacteria in a bid to protect themselves against viruses, but what was developed with this elegant technology platform, which essentially can be envisioned as a pair of molecular scissors attached to a barcode, which can then

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About CRSP

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on CRSP

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.